mRNA + Cell and Gene = ???
Calling all advanced therapy thought leaders: we want your hot takes!
Angus Stewart | | Quick Read
Have you heard about The Medicine Maker’s new regular feature: the Cell & Gene Champions? Every two months we pose one of the hottest questions facing the field, and ask for answers from experts in the industry.
In the inaugural Champions feature, we posed the question ‘Where do the biggest skills shortages exist in this field – and how should we address the problem?’, and published answers from four professionals hailing from a national institution, a professional body, a startup, and a tech company. Every take was a little different and the answers made for a fascinating read.
For our second installment of the feature, we decided to put the topic question to a vote in the Cell + Gene Curator, our weekly roundup of the top news in advanced therapies.
In the poll, we pitted 'How will developments in mRNA affect the cell + gene field?' against ‘Is automation a panacea to the manufacturing challenges in cell + gene?’ It was a close contest, but mRNA just had the edge, claiming 52 percent of the votes.
Now, we’re searching for answers. Is mRNA going to revolutionize the field, or would we be wise not to overhype its impact? And what exactly will the nature of that impact be? It’s all up in the air, and that is precisely why we want to hear from you.
If you’ve got an opinion on mRNA in advanced therapy and want it heard, then submit your thoughts to [email protected]. We'll be publishing the very best responses in print and online. If you have a professional photo of yourself to hand, it would be great if you could attach that to your email.
There's only two rules:
- Word count must land between 200 to 300 words.
- No sales pitches or self-promotion, please!
This is a chance for you to show off your knowledge and devotion to the field, and get your view across to thousands of readers working in the industry. So, come on champion, let’s get your take!